Why the study?
Does ultrasound-measured plaque strain predict vascular cognitive decline, microemboli, and white matter changes in asymptomatic patients with significant carotid artery stenosis?
Does ultrasound-measured plaque strain predict vascular cognitive decline, microemboli, and white matter changes in asymptomatic patients with significant carotid artery stenosis?
Ultrasound-measured plaque strain instability predicts vascular cognitive decline and correlates with microemboli and white matter hyperintensities in asymptomatic patients with >60% carotid stenosis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for cognitive risk stratification in asymptomatic carotid stenosis; prospective trials needed before clinical adoption.
OBJECTIVE This article describes the use of ultrasound measurements of physical strain within carotid atherosclerotic plaques as a measure of instability and the potential for vascular cognitive decline, microemboli, and white matter changes. METHODS Asymptomatic patients with significant (> 60%) carotid artery stenosis were studied for dynamic measures of plaque instability, presence of microemboli, white matter changes, and vascular cognitive decline in comparison with normative controls and premorbid state. RESULTS Although classically asymptomatic, these patients showed vascular cognitive decline. The degree of strain instability measured within the atherosclerotic plaque directly predicted vascular cognitive decline in these patients thought previously to be asymptomatic according to classic criteria. Furthermore, 26% of patients showed microemboli, and patients had twice as much white matter hyperintensity as controls. CONCLUSIONS These data show that physical measures of plaque instability are possible through interpretation of ultrasound strain data during pulsation, which may be more clinically relevant than solely measuring degree of stenosis. The data also highlight the importance of understanding that the definition of symptoms should not be limited to motor, speech, and vision function but underscore the role of vascular cognitive decline in the pathophysiology of carotid atherosclerotic disease. Clinical trial registration no.: NCT02476396 (clinicaltrials.gov).
No takes yet. Share an insight, caveat, or question.
Dempsey et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: